Marcuzzi A - Search Results

1

Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency.

Marcuzzi A, Pontillo A, De Leo L, Tommasini A, Decorti G, Not T, Ventura A. Marcuzzi A, et al. Pediatr Res. 2008 Aug;64(2):177-82. doi: 10.1203/PDR.0b013e3181761870. Pediatr Res. 2008. PMID: 18391837

2

Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency.

Marcuzzi A, Decorti G, Pontillo A, Ventura A, Tommasini A. Marcuzzi A, et al. Inflamm Res. 2010 May;59(5):335-8. doi: 10.1007/s00011-010-0168-6. Epub 2010 Feb 21. Inflamm Res. 2010. PMID: 20174853

3

Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.

De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A. De Leo L, et al. Among authors: marcuzzi a. Pharmacol Res. 2010 Jun;61(6):506-10. doi: 10.1016/j.phrs.2010.02.012. Epub 2010 Mar 3. Pharmacol Res. 2010. PMID: 20206266

4

Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes.

Marcuzzi A, Tommasini A, Crovella S, Pontillo A. Marcuzzi A, et al. Int Immunopharmacol. 2010 Jun;10(6):639-42. doi: 10.1016/j.intimp.2010.03.008. Epub 2010 Mar 18. Int Immunopharmacol. 2010. PMID: 20304105

5

Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency.

Marcuzzi A, Crovella S, Pontillo A. Marcuzzi A, et al. In Vivo. 2011 Jan-Feb;25(1):87-92. In Vivo. 2011. PMID: 21282739

6

Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).

Marcuzzi A, Zanin V, Crovella S, Pontillo A. Marcuzzi A, et al. Oral Oncol. 2011 May;47(5):436-7; author reply 438. doi: 10.1016/j.oraloncology.2011.02.017. Epub 2011 Mar 15. Oral Oncol. 2011. PMID: 21411362 No abstract available.

7

The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.

Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A. Marcuzzi A, et al. Pediatr Res. 2011 Jul;70(1):78-82. doi: 10.1203/PDR.0b013e31821b581c. Pediatr Res. 2011. PMID: 21430599

8

Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes.

Marcuzzi A, Piscianz E, Girardelli M, Crovella S, Pontillo A. Marcuzzi A, et al. Apoptosis. 2011 Sep;16(9):882-8. doi: 10.1007/s10495-011-0621-1. Apoptosis. 2011. PMID: 21667041

9

Inflammation profile of four early onset Crohn patients.

Marcuzzi A, Girardelli M, Bianco AM, Martelossi S, Magnolato A, Tommasini A, Crovella S. Marcuzzi A, et al. Gene. 2012 Feb 10;493(2):282-5. doi: 10.1016/j.gene.2011.11.043. Epub 2011 Dec 6. Gene. 2012. PMID: 22155628

10

A common genetic background could explain early-onset Crohn's disease.

Bianco AM, Zanin V, Girardelli M, Magnolato A, Martelossi S, Tommasini A, Marcuzzi A, Crovella S. Bianco AM, et al. Among authors: marcuzzi a. Med Hypotheses. 2012 Apr;78(4):520-2. doi: 10.1016/j.mehy.2012.01.023. Epub 2012 Feb 10. Med Hypotheses. 2012. PMID: 22309886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters